[1]
Sayar, S. et al. 2020. Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection. Turkish Journal of Gastroenterology. 31, 7 (Jan. 2020), 522–528. DOI:https://doi.org/10.5152/tjg.2020.19295.